US Stock MarketDetailed Quotes

Seres Therapeutics (MCRB)

Watchlist
  • 7.610
  • +0.240+3.26%
Close May 1 16:00 ET
  • 7.610
  • 0.0000.00%
Post 16:10 ET
73.30MMarket Cap11.89P/E (TTM)

Seres Therapeutics (MCRB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
100.75%1.12M
62.17%-14.71M
106.36%2.21M
66.62%-13.29M
176.37%26.91M
-26.63%-148.61M
18.14%-38.88M
41.47%-34.68M
-160.33%-39.81M
53.99%-35.24M
Net income from continuing operations
4,088.24%5.7M
1.93%-15.34M
-90.76%8.2M
39.60%-19.86M
181.43%32.68M
100.12%136K
62.09%-15.64M
285.51%88.78M
-170.61%-32.87M
43.61%-40.13M
Operating gains losses
99.84%-192K
----
----
----
----
-174,163.38%-123.59M
105.85%24K
-12,089.33%-123.36M
---130K
---123K
Depreciation and amortization
-24.41%4.13M
-12.07%954K
-25.64%1.04M
-25.42%1.06M
-30.98%1.08M
-12.41%5.47M
-33.52%1.09M
-16.63%1.4M
-7.01%1.42M
11.36%1.56M
Other non cash items
-20.89%8.42M
8.92%2.19M
-26.88%2.13M
-28.13%2.06M
-28.45%2.05M
-29.83%10.64M
-29.08%2.01M
42.38%2.91M
-35.21%2.87M
-51.26%2.86M
Change In working capital
57.59%-27.78M
81.67%-5.52M
-21.43%-11.65M
106.63%1.1M
-27.96%-11.71M
-11.08%-65.51M
-95.76%-30.13M
57.90%-9.59M
-1,036.41%-16.64M
52.67%-9.15M
-Change in receivables
-76.52%1.55M
112.57%260K
-99.44%105K
116.80%1.88M
-155.18%-693K
176.16%6.61M
-125.27%-2.07M
300.05%18.6M
-47.94%-11.18M
--1.26M
-Change in inventory
--0
--0
--0
--0
--0
-13.99%-33.8M
--0
20.78%-10.45M
-106.44%-11.02M
---12.33M
-Change in prepaid assets
175.58%2.72M
-97.38%19K
69.62%-688K
208.72%2.04M
-69.47%1.35M
103.39%987K
102.30%726K
-110.70%-2.27M
-451.40%-1.88M
44.74%4.41M
-Change in payables and accrued expense
18.95%-23.38M
86.89%-3.51M
1.95%-8.89M
-107.29%-706K
-287.62%-10.27M
-777.09%-28.84M
-224.48%-26.81M
-100.98%-9.06M
-3.83%9.68M
88.40%-2.65M
-Change in other current liabilities
-36.84%-8.67M
-15.97%-2.29M
-3.56%-2.18M
-3.48%-2.11M
-859.63%-2.09M
-188.53%-6.34M
-250.89%-1.97M
-99.05%-2.11M
-300.59%-2.04M
-225.37%-218K
-Change in other working capital
----
----
----
----
----
-164.39%-4.12M
--0
-168.10%-4.32M
-113.91%-187K
-27.39%379K
Cash from discontinued investing activities
Operating cash flow
100.75%1.12M
62.17%-14.71M
106.36%2.21M
66.62%-13.29M
176.37%26.91M
-26.63%-148.61M
18.14%-38.88M
41.47%-34.68M
-160.33%-39.81M
53.99%-35.24M
Investing cash flow
Cash flow from continuing investing activities
-100.03%-42K
301.11%181K
-100.01%-8K
-113.90%-181K
45.16%-34K
1,244.67%142.29M
89.74%-90K
7,954.37%141.14M
-87.62%1.3M
-102.26%-62K
Net PPE purchase and sale
88.95%-42K
301.11%181K
93.80%-8K
-82.83%-181K
45.16%-34K
95.24%-380K
89.74%-90K
92.82%-129K
91.97%-99K
98.48%-62K
Net business purchase and sale
--0
--0
----
----
----
--141.27M
--0
----
----
----
Net investment purchase and sale
--0
----
----
----
----
--0
--0
--0
--0
--0
Net other investing changes
----
----
----
----
----
--1.4M
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
-100.03%-42K
301.11%181K
-100.01%-8K
-113.90%-181K
45.16%-34K
1,244.67%142.29M
89.74%-90K
7,954.37%141.14M
-87.62%1.3M
-102.26%-62K
Financing cash flow
Cash flow from continuing financing activities
115.38%13.9M
628.67%12.66M
100.06%61K
0
-93.71%1.18M
-226.03%-90.37M
-72.98%1.74M
-7,783.37%-110.87M
0
231.72%18.76M
Net issuance payments of debt
--0
--0
----
----
----
-353.19%-127.91M
--0
---127.91M
----
----
Net common stock issuance
-44.04%13.17M
600.69%12.17M
--0
--0
-94.59%996K
29.58%23.53M
-72.98%1.74M
--3.38M
--0
334.28%18.41M
Proceeds from stock option exercised by employees
50.10%731K
--486K
-54.48%61K
--0
-47.88%184K
-83.92%487K
--0
-90.71%134K
--0
-75.09%353K
Net other financing activities
----
----
----
----
----
--13.52M
--0
----
----
----
Cash from discontinued financing activities
Financing cash flow
115.38%13.9M
628.67%12.66M
100.06%61K
--0
-93.71%1.18M
-226.03%-90.37M
-72.98%1.74M
-7,783.37%-110.87M
--0
231.72%18.76M
Net cash flow
Beginning cash position
-71.02%39.46M
-26.59%56.31M
-33.36%54.05M
-43.55%67.52M
-71.02%39.46M
-20.48%136.15M
-56.94%76.7M
-65.88%81.11M
16.10%119.61M
-20.48%136.15M
Current changes in cash
115.49%14.97M
94.97%-1.87M
151.25%2.26M
65.02%-13.47M
269.67%28.06M
-175.72%-96.69M
11.23%-37.24M
92.61%-4.41M
-128.59%-38.51M
75.75%-16.54M
Effect of exchange rate changes
--0
----
----
----
----
-150.00%-1K
---1K
--0
----
----
End cash Position
37.94%54.43M
37.94%54.43M
-26.59%56.31M
-33.36%54.05M
-43.55%67.52M
-71.02%39.46M
-71.02%39.46M
-56.94%76.7M
-65.88%81.11M
16.10%119.61M
Free cash flow
100.58%865K
62.18%-14.74M
106.31%2.2M
66.25%-13.47M
176.14%26.88M
-18.88%-148.99M
19.44%-38.97M
42.98%-34.81M
-161.64%-39.91M
56.23%-35.3M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 100.75%1.12M62.17%-14.71M106.36%2.21M66.62%-13.29M176.37%26.91M-26.63%-148.61M18.14%-38.88M41.47%-34.68M-160.33%-39.81M53.99%-35.24M
Net income from continuing operations 4,088.24%5.7M1.93%-15.34M-90.76%8.2M39.60%-19.86M181.43%32.68M100.12%136K62.09%-15.64M285.51%88.78M-170.61%-32.87M43.61%-40.13M
Operating gains losses 99.84%-192K-----------------174,163.38%-123.59M105.85%24K-12,089.33%-123.36M---130K---123K
Depreciation and amortization -24.41%4.13M-12.07%954K-25.64%1.04M-25.42%1.06M-30.98%1.08M-12.41%5.47M-33.52%1.09M-16.63%1.4M-7.01%1.42M11.36%1.56M
Other non cash items -20.89%8.42M8.92%2.19M-26.88%2.13M-28.13%2.06M-28.45%2.05M-29.83%10.64M-29.08%2.01M42.38%2.91M-35.21%2.87M-51.26%2.86M
Change In working capital 57.59%-27.78M81.67%-5.52M-21.43%-11.65M106.63%1.1M-27.96%-11.71M-11.08%-65.51M-95.76%-30.13M57.90%-9.59M-1,036.41%-16.64M52.67%-9.15M
-Change in receivables -76.52%1.55M112.57%260K-99.44%105K116.80%1.88M-155.18%-693K176.16%6.61M-125.27%-2.07M300.05%18.6M-47.94%-11.18M--1.26M
-Change in inventory --0--0--0--0--0-13.99%-33.8M--020.78%-10.45M-106.44%-11.02M---12.33M
-Change in prepaid assets 175.58%2.72M-97.38%19K69.62%-688K208.72%2.04M-69.47%1.35M103.39%987K102.30%726K-110.70%-2.27M-451.40%-1.88M44.74%4.41M
-Change in payables and accrued expense 18.95%-23.38M86.89%-3.51M1.95%-8.89M-107.29%-706K-287.62%-10.27M-777.09%-28.84M-224.48%-26.81M-100.98%-9.06M-3.83%9.68M88.40%-2.65M
-Change in other current liabilities -36.84%-8.67M-15.97%-2.29M-3.56%-2.18M-3.48%-2.11M-859.63%-2.09M-188.53%-6.34M-250.89%-1.97M-99.05%-2.11M-300.59%-2.04M-225.37%-218K
-Change in other working capital ---------------------164.39%-4.12M--0-168.10%-4.32M-113.91%-187K-27.39%379K
Cash from discontinued investing activities
Operating cash flow 100.75%1.12M62.17%-14.71M106.36%2.21M66.62%-13.29M176.37%26.91M-26.63%-148.61M18.14%-38.88M41.47%-34.68M-160.33%-39.81M53.99%-35.24M
Investing cash flow
Cash flow from continuing investing activities -100.03%-42K301.11%181K-100.01%-8K-113.90%-181K45.16%-34K1,244.67%142.29M89.74%-90K7,954.37%141.14M-87.62%1.3M-102.26%-62K
Net PPE purchase and sale 88.95%-42K301.11%181K93.80%-8K-82.83%-181K45.16%-34K95.24%-380K89.74%-90K92.82%-129K91.97%-99K98.48%-62K
Net business purchase and sale --0--0--------------141.27M--0------------
Net investment purchase and sale --0------------------0--0--0--0--0
Net other investing changes ----------------------1.4M--0--0--------
Cash from discontinued investing activities
Investing cash flow -100.03%-42K301.11%181K-100.01%-8K-113.90%-181K45.16%-34K1,244.67%142.29M89.74%-90K7,954.37%141.14M-87.62%1.3M-102.26%-62K
Financing cash flow
Cash flow from continuing financing activities 115.38%13.9M628.67%12.66M100.06%61K0-93.71%1.18M-226.03%-90.37M-72.98%1.74M-7,783.37%-110.87M0231.72%18.76M
Net issuance payments of debt --0--0-------------353.19%-127.91M--0---127.91M--------
Net common stock issuance -44.04%13.17M600.69%12.17M--0--0-94.59%996K29.58%23.53M-72.98%1.74M--3.38M--0334.28%18.41M
Proceeds from stock option exercised by employees 50.10%731K--486K-54.48%61K--0-47.88%184K-83.92%487K--0-90.71%134K--0-75.09%353K
Net other financing activities ----------------------13.52M--0------------
Cash from discontinued financing activities
Financing cash flow 115.38%13.9M628.67%12.66M100.06%61K--0-93.71%1.18M-226.03%-90.37M-72.98%1.74M-7,783.37%-110.87M--0231.72%18.76M
Net cash flow
Beginning cash position -71.02%39.46M-26.59%56.31M-33.36%54.05M-43.55%67.52M-71.02%39.46M-20.48%136.15M-56.94%76.7M-65.88%81.11M16.10%119.61M-20.48%136.15M
Current changes in cash 115.49%14.97M94.97%-1.87M151.25%2.26M65.02%-13.47M269.67%28.06M-175.72%-96.69M11.23%-37.24M92.61%-4.41M-128.59%-38.51M75.75%-16.54M
Effect of exchange rate changes --0-----------------150.00%-1K---1K--0--------
End cash Position 37.94%54.43M37.94%54.43M-26.59%56.31M-33.36%54.05M-43.55%67.52M-71.02%39.46M-71.02%39.46M-56.94%76.7M-65.88%81.11M16.10%119.61M
Free cash flow 100.58%865K62.18%-14.74M106.31%2.2M66.25%-13.47M176.14%26.88M-18.88%-148.99M19.44%-38.97M42.98%-34.81M-161.64%-39.91M56.23%-35.3M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More